Timothy L. McCavit earned a MS in molecular biology at Texas Tech University and a Medical Doctorate at UT Southwestern Medical Center in Dallas. Dr. McCavit completed a Residency and a MS in Clinical Sciences at UT Southwestern. Dr. McCavit is board certified in Pediatric Hematology/Oncology.

In his clinical practice, Dr. McCavit focuses on the care of children with sickle cell disease. Dr. McCavit has a research interest in long-term outcomes for children with sickle cell disease. His published work to date has examined early death, stroke, and infection by streptococcus pneumoniae in young sickle cell patients.

In addition, Dr. McCavit has a research interest in quality-of-care (QOC) and has completed studies evaluating novel QOC indicators for sickle cell pain and febrile neutropenia in pediatric cancer patients. He also has a research interest in iron deficiency anemia including clinical trials for the treatment of newly-diagnosed and refractory iron deficiency anemia in children.

Representative Publications:

Timing of opioid administration as a quality indicator for pain crises in sickle cell disease

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia

Prophylactic penicillin after 5 years of age in patients with sickle cell disease: a survey of sickle cell disease experts

National trends in incidence rates of hospitalization for stroke in children with sickle cell disease

Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure

Share

Discuss in Social Wall

Twitter

Share to SCDteam

+myBinder